Elevated exhaled nitric oxide (NO) in asymptomatic asthmatics taking bronchodilators on demand with controlled body composition

Journal of the Pakistan Medical Association

Volumn 59, Issue 3, 2009, Pages 147-150

  Habib, Syed Shahid ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; NITRIC OXIDE;

ARTICLE; ASTHMA; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; OBSTRUCTIVE AIRWAY DISEASE; RESPIRATORY FUNCTION;

ADULT; ASTHMA; BIOLOGICAL MARKERS; BODY COMPOSITION; BREATH TESTS; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; RESPIRATORY FUNCTION TESTS;

EID: 63049128610     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncadas. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181:852-7.
2. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI. NIH conference: airway inflammation. Ann Intern Med 1995;123: 288-304.
3. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts. Lancet 2002; 360:1715-21.
4. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-5.
5. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157:894-8.
6. Hart CM. Nitric oxide in adult lung disease. Chest 1999; 115:1407-17.
7. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152: 800-3.
8. Silkoff PE, Wakita S, Chatkin J, et al.: Exhaled nitric oxide after beta2 agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med 1999; 159: 940-4.
9. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004; 170:1281-5.
10. Cerveri I, Zoia MC, Bugiani M, Corsico A, Carosso A, Piccioni P, et al. Inadequate antiasthma drug use in the north of Italy. Eur Respir J 1997; 10:2761-5.
11. American Thoracic Society, European Respiratory Society (ATS/ERS). Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-30.
12. Tashkin DP. The role of small airway inflammation in asthma. Allergy Asthma Proc 2002; 23:233-42.
13. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001; 344:350-62.
14. Zeidler MR; Kleerup EC; Tashkin DP. Exhaled Nitric Oxide in the Assessment of Asthma. Curr Opin Pulm Med 2004; 10:31-6.
15. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169:473-8.
16. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:892-6.
17. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002; 19:1015-9.
18. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41:471-6.
19. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest. 2003; 123:751-6.
20. Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007; 176:238-42.
21. Katial R, Stewart L. Exhaled nitric oxide: a test for diagnosis and control of asthma? Curr Allergy Asthma Rep 2007; 7:459-63.
22. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-73.
23. Kharitonov SA, Donnelly LE, Montuschi P, Cowadi M, Collins JV, et al. Dose- dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57:889-96.
24. Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003; 167:1232-8.
25. Jones SL, Herbison P, Cowan JO, et al.: Exhaled NO and assessment of anti- inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002; 20:601-8.